Propranolol alone may not be acceptable to prevent first esopfaageal variceal bleeding in Japanese cirrhotic patients: Randomized controlled trial

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 5, 2004, Pages 576-581

  Tomikawa, Morimasa ^a   Shimabukuro, Rinshun ^a   Okita, Keishi ^a   Tsutsumi, Norifumi ^a   Akahoshi, Tomohiko ^a   Hashizume, Makoto ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Endoscopic injection sclerotherapy; Esophageal varices; Propranolol

Indexed keywords

PROPRANOLOL DERIVATIVE;

ADULT; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS HEMORRHAGE; ESOPHAGUS STRICTURE; ESOPHAGUS VARICES; FATIGUE; FEMALE; FEVER; HUMAN; JAPAN; LIVER CIRRHOSIS; MALE; NAUSEA; PRIORITY JOURNAL; PROBABILITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THORAX PAIN;

EID: 2442655165     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2003.03331.x     Document Type: Article

References (32)

1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-9.
2. The Italian Multicenter Project for Propranolol in Prevention of Bleeding. Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial. J. Hepatol. 1989; 9: 75-83.
3. Paquet KJ. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices - a prospective controlled randomized trial. Endoscopy 1982; 14: 4-5.
4. Pascal JP, Cales P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N. Engl. J. Med. 1987; 317: 856-61.
5. Lebrec D, Poynard T, Bernuau J et al. A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology 1984; 4: 355-8.
6. Bhathal PS, Grossman HJ. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J. Hepatol. 1985; 1: 325-37.
7. Lebrec D, Hillon P, Munoz C, Goldfarb G, Nouel O, Benhamou JP. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982; 2: 523-7.
8. Tomikawa M, Hashizume M, Okita K et al. Endoscopic injection sclerotherapy in the management of 2105 patients with esophageal varices. Surgery 2002; 131: S171-5.
9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-9.
10. Beppu K, Inokuchi K, Koyanagi N et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest. Endosc. 1981; 27: 213-8.
11. Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society for Portal Hypertension. World J. Surg. 1995; 19: 420-3.
12. Kitano S, Koyanagi N, Iso Y, Iwanaga T, Higashi H, Sugimachi K. Prospective randomized trial comparing two injection techniques for sclerosing oesophageal varices: over-tube and free-hand. Br. J. Surg. 1987; 74: 603-6.
13. Kitano S, Koyanagi N, Iso Y, Higashi H, Sugimachi K. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Hepatology 1987; 7: 810-5.
14. Hashizume M, Ohta M, Kawanaka H, Kishihara F, Sugimachi K. Recurrence rate of oesophageal varices with endoscopic banding ligation followed by injection sclerotherapy. Lancet 1994; 344: 1643.
15. Sharara AI, Rockey DC. Gastroesophageal variceal hemorrhage. N. Engl. J. Med. 2001; 345: 669-81.
16. Conn HO, Grace ND, Bosch J et al. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: a multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatol. 1991; 13: 902-12.
17. Poynard T, Cales P, Pasta L et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N. Engl. J. Med. 1991; 324: 1532-8.
18. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis. 1999; 19: 475-505.
19. Pagliaro L, D'Amico G, Sorensen TI et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann. Intern. Med. 1992; 117: 59-70.
20. Teran JC, Imperiale TF, Mullen KD, Tavill AS, McCullough AJ. Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. Gastroenterology 1997; 112: 473-82.
21. Teres J, Bosch J, Bordas JM et al. Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial. Gastroenterology 1993; 105: 1508-14.
22. The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. N. Engl. J. Med. 1991; 324: 1779-84.
23. Inokuchi K. Improved survival after prophylactic portal nondecompression surgery for esophageal varices: a randomized clinical trial. Cooperative Study Group of Portal Hypertension of Japan. Hepatol. 1990; 12: 1-6.
24. Robertson CS, Womack C, Robson K, Morris DL. A study of the local toxicity of agents used for variceal injection sclerotherapy. HPB Surg. 1989; 1: 149-54.
25. Kitano S, Wada H, Yamaga H et al. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices. J. Gastroenterol. Hepatol. 1991; 6: 476-80.
26. Hashizume M, Kitano S, Koyanagi N et al. Endoscopic injection sclerotherapy for 1,000 patients with esophageal varices: a nine-year prospective study. Hepatology 1992; 15: 69-75.
27. D'Amico G, Pasta L, Madonia S et al. The incidence of esophageal varices in cirrhosis (Abstract). Gastroenterology 2001; 120: A2.
28. Jensen DN. Endoscopic screening for varices in cirrhosis. Findings, implications, outcomes. Gastroenterol. 2002; 122: 1620-30.
29. Dagradi AE. The natural history of esophageal varices in patients with alcoholic liver cirrhosis. An endoscopic and clinical study. Am. J. Gastroenterol. 1972; 57: 520-40.
30. Garcia-Tsao G, Grace ND, Groszmann RJ et al. Short-term effects of propranolol on portal venous pressure. Hepatology 1986; 6: 101-6.
31. Stiegmann GV, Goff JS, Michaletz-Onody PA et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N. Engl. J. Med. 1992; 326: 1527-32.
32. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N. Engl. J. Med. 1999; 340: 988-93.